Complete radiographic responses in pediatric patients with BRAFV600-positive tumors including high-grade gliomas: Preliminary results of an ongoing phase 1/2a safety and pharmacokinetics (PK) study of dabrafenib.
Mark W. Kieran
No relevant relationships to disclose
Kenneth J. Cohen
Research Funding - GlaxoSmithKline
Francois Doz
No relevant relationships to disclose
Ira J. Dunkel
Research Funding - GlaxoSmithKline
Darren R Hargrave
No relevant relationships to disclose
Trent Ryan Hummel
No relevant relationships to disclose
Irene Jimenez
No relevant relationships to disclose
Sarah Leary
Research Funding - GlaxoSmithKline
Andrew DJ Pearson
No relevant relationships to disclose
Christine A. Pratilas
Research Funding - GlaxoSmithKline
James Whitlock
Consultant or Advisory Role - GlaxoSmithKline (U)
Research Funding - GlaxoSmithKline
Michael Durante
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Diana M. Gibson
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Patricia Haney
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Mark W. Russo
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Benjamin B. Suttle
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Birgit Geoerger
No relevant relationships to disclose